Skip to main content
. 2019 Sep 19;2(3):803–812. doi: 10.20517/cdr.2019.009

Figure 1.

Figure 1

A summary of the signaling connections between ALK and MYCN in neuroblastoma. The red boxes describe current therapeutic approaches that are being pursued either preclinically or in clinical studies